BACKGROUND: In the absence of clinical evidence of cardiac allograft rejection, it is still poorly defined whether the International Society for Heart and Lung Transplantation biopsy grade 2 (e.g., focal moderate rejection) should be treated. Aim of the present study was to retrospectively investigate the evolution of focal moderate rejection, diagnosed during the first postoperative year in patients who had undergone orthotopic heart transplantation. METHODS: A retrospective analysis was conducted on 256 International Society for Heart and Lung Transplantation grade 2 biopsies from 110 orthotopic heart transplantations; 125 episodes occurred within the first 3 months (group 1), 131 later (group 2). For each grade 2 diagnosis, two biopsies,...
Introduction. Endomyocardial biopsy (EMB) plays an important role in allograft surveillance to scree...
International audienceThis study was designed retrospectively to assess the value of myocardial T2 t...
Background: Despite the risk for complications, allograft surveillance after orthotopic heart transp...
BACKGROUND: In the absence of clinical evidence of cardiac allograft rejection, it is still poorly d...
The endomyocardial biopsy (EMB) in heart transplant recipients has been considered the "gold standar...
Acute cellular rejection (ACR) the first year after heart transplantation (HT) and its impact on sur...
Routine endomyocardial biopsy (EMB) to detect acute cellular rejection (ACR) late (>1 year) after he...
none13noBackground Primary graft dysfunction (P-GD) is the leading cause of early mortality after he...
BACKGROUND: Endomyocardial biopsy (EMB) remains the gold standard for the diagnosis of graft rejecti...
BACKGROUND: To determine mechanisms that trigger graft vascular disease (GVD) after heart transplant...
Background: Endomyocardial biopsy (EMB) is the gold standard method for surveillance of acute cardia...
The shortage of donor hearts emphasizes the importance of an optimal selection among candidates for ...
International audienceThis study was designed retrospectively to assess the value of myocardial T2 t...
To evaluate the association between mild acute cellular rejection (ACR) and the development of cardi...
Introduction. Endomyocardial biopsy (EMB) plays an important role in allograft surveillance to scree...
International audienceThis study was designed retrospectively to assess the value of myocardial T2 t...
Background: Despite the risk for complications, allograft surveillance after orthotopic heart transp...
BACKGROUND: In the absence of clinical evidence of cardiac allograft rejection, it is still poorly d...
The endomyocardial biopsy (EMB) in heart transplant recipients has been considered the "gold standar...
Acute cellular rejection (ACR) the first year after heart transplantation (HT) and its impact on sur...
Routine endomyocardial biopsy (EMB) to detect acute cellular rejection (ACR) late (>1 year) after he...
none13noBackground Primary graft dysfunction (P-GD) is the leading cause of early mortality after he...
BACKGROUND: Endomyocardial biopsy (EMB) remains the gold standard for the diagnosis of graft rejecti...
BACKGROUND: To determine mechanisms that trigger graft vascular disease (GVD) after heart transplant...
Background: Endomyocardial biopsy (EMB) is the gold standard method for surveillance of acute cardia...
The shortage of donor hearts emphasizes the importance of an optimal selection among candidates for ...
International audienceThis study was designed retrospectively to assess the value of myocardial T2 t...
To evaluate the association between mild acute cellular rejection (ACR) and the development of cardi...
Introduction. Endomyocardial biopsy (EMB) plays an important role in allograft surveillance to scree...
International audienceThis study was designed retrospectively to assess the value of myocardial T2 t...
Background: Despite the risk for complications, allograft surveillance after orthotopic heart transp...